Lentiviral/retroviral vector large scale manufacturing

被引：0
|
作者：
Bellintani, F. [1 ]
Neri, M. [1 ]
Rossetti, F. [1 ]
Cota, M. [1 ]
Crippa, L. [1 ]
Piovani, B. [1 ]
Simonetti, E. [1 ]
Allievi, L. [1 ]
Corbetta, S. [1 ]
Lorenzetti, F. [1 ]
Testasecca, A. [1 ]
Pedregal, A. [2 ]
Vallanti, G. [1 ]
机构：
[1] MolMed SpA, Milan, Italy
[2] Pall Life Sci, New York, NY USA
来源：
HUMAN GENE THERAPY | 2018年 / 29卷 / 12期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
P457
引用
收藏
页码：A158 / A159
页数：2
相关论文
共 50 条
  • [21] GMP Manufacturing of Lentiviral Vectors: Capacity and Scale Considerations
    Miskin, James
    Mitrophanous, Kyriacos
    Knevelman, Carol
    McFarlane, Mardon
    Jones, Peter
    Simpkins, Simon
    MOLECULAR THERAPY, 2017, 25 (05) : 227 - 228
  • [22] GMP manufacturing of lentiviral vectors: Scale up considerations
    Davies, L.
    Knevelman, C.
    Carter, R.
    Pardo, H.
    Jones, P.
    Mitrophanous, K.
    Miskin, J.
    Malabre, K.
    HUMAN GENE THERAPY, 2019, 30 (08) : A25 - A25
  • [23] Targeting retroviral and lentiviral vectors
    Sandrin, V
    Russell, SJ
    Cosset, FL
    CELLULAR FACTORS INVOLVED IN EARLY STEPS OF RETROVIRAL REPLICATION, 2003, 281 : 137 - 178
  • [24] The Influence of Vector Design on Integration Site Selection by gamma-Retroviral and Lentiviral Vectors
    Recchia, Alessandra
    Cattoglio, Claudia
    Miccio, Annarita
    Antonelli, Antonella
    Testa, Anna
    Facchini, Giulia
    Sartori, Daniela
    Ferrari, Giuliana
    Mavilio, Fulvio
    MOLECULAR THERAPY, 2006, 13 : S284 - S284
  • [25] Development of Novel Lipoplex Formulation Methodologies to Improve Large Scale Transient Transfection for Lentiviral Vector Manufacture
    Williams, Thomas
    Knevelman, Carol
    Mitrophanous, Kyri
    Miskin, James E.
    Davies, Lee
    Rafiq, Qasim
    MOLECULAR THERAPY, 2023, 31 (04) : 751 - 751
  • [26] Transient transfection at large scale for clinical AAV9 vector manufacturing
    Legmann, R.
    CYTOTHERAPY, 2020, 22 (05) : S151 - S151
  • [27] Large-Scale Production of Clinical Grade Lentiviral Vector in a Closed System Hollow Fiber Bioreactor
    Sheu, Jonathan
    Fury, Brian
    Tobin, Steve
    Falconer, Danny
    Beltzer, Jim
    Bauer, Gerhard
    MOLECULAR THERAPY, 2014, 22 : S281 - S282
  • [28] Assessment of changes in gene expression caused by insertions of a globin lentiviral vector containing globin regulatory elements or a lentiviral vector containing retroviral LTR elements.
    Hargrove, PW
    Kepes, S
    Hanawa, H
    Cheng, C
    Neale, G
    Nienhuis, AW
    Persons, DA
    BLOOD, 2004, 104 (11) : 145A - 145A
  • [29] Large-scale Clinical-grade Retroviral Vector Production in a Fixed-Bed Bioreactor
    Wang, Xiuyan
    Olszewska, Malgorzata
    Qu, Jinrong
    Wasielewska, Teresa
    Bartido, Shirley
    Hermetet, Gregory
    Sadelain, Michel
    Riviere, Isabelle
    JOURNAL OF IMMUNOTHERAPY, 2015, 38 (03) : 127 - 135
  • [30] Large-Scale Clinical Grade Retroviral Vector Production using a Fixed-bed Bioreactor
    Wang, Xiuyan
    Olszewska, Malgorzata
    Qu, Jinrong
    Wasielewska, Teresa
    Hermetet, Gregory
    Sadelain, Michel
    Riviere, Isabelle
    HUMAN GENE THERAPY, 2014, 25 (11) : A88 - A89
12345